News
News Center
Time-honored brand Jiuzhitang joins hands with JD Health to create a new benchmark for "Internet + Healthcare" services.
2021-04-02
On April 1, 2021, JD Health officially announced a strategic partnership with the time-honored brand Jiuzhitang. The two companies will collaborate across multiple areas, including retail of pharmaceuticals and wellness products, academic marketing, the "Yaojingcai" supply chain, and internet-based healthcare resources.
Both parties will focus on Jiuzhitang's high-quality products and services, leveraging JD Health's robust ecosystem resources in key business areas such as pharmaceutical supply chains, internet-based healthcare, health management, and smart medical solutions. Together, they will accelerate the digital transformation and modernization of the pharmaceutical distribution sector, delivering superior, more convenient, and safer healthcare services to users nationwide.
Leveraging complementary strengths to serve the new era of national health
Health is a timeless topic that captures people's attention. Following the report from the 19th National Congress of the Communist Party of China, which called for "implementing the Healthy China Strategy," the COVID-19 pandemic has awakened public awareness of "national health" and "comprehensive well-being." As a result, the greater health industry has truly entered an era driven by "universal demand." Moreover, the country’s 14th Five-Year Plan explicitly prioritizes "fully advancing the construction of a Healthy China" as a key development objective. Standing at this new historical juncture, the health industry now faces unprecedented opportunities for growth and innovation. The dynamic new era also presents a significant chance for both sides to forge strategic partnerships and unlock even greater potential for collaboration.
Jiuzhitang is a time-honored enterprise with a history of 371 years, renowned for its century-old brand heritage and cultural legacy, as well as its robust production quality assurance system. With a diverse product portfolio and extensive medical resources, the company has established itself as a highly valuable and dynamic brand in the traditional Chinese medicine sector. Deeply rooted in both traditional and modern Chinese herbal medicine, Jiuzhitang is also pioneering innovations in the "medicine-food homology" wellness space and expanding into stem-cell-based biopharmaceuticals. Additionally, the company has launched an online Traditional Chinese Medicine hospital, ensuring that this century-old brand continues to align seamlessly with the evolving health needs of people in the new era.
As a leading online healthcare platform in China and a pioneer in digitally transforming the medical industry chain, JD Health’s products and services span the entire physical pharmaceutical and healthcare supply chain, cover every stage of medical care, cater to all health-related scenarios, and support users throughout their entire life cycle—ultimately creating a comprehensive and integrated "Internet + Healthcare" ecosystem.
The unique strengths and resources in their respective fields, coupled with a shared commitment to advancing health initiatives, form the foundation of the strategic partnership between JD Health and Jiuzhitang. The two companies have aligned their collaboration around three key areas: pharmaceuticals, greater-health products, and customized product sales, as well as the "Yaojingcai" supply chain and "Internet + Healthcare" services—aiming to achieve mutual complementarity, win-win cooperation, and sustained growth.
Jointly Building a New Ecosystem for "Internet + Healthcare" Services
Through this strategic partnership, JD Health will fully open up its "Internet + Healthcare" ecosystem capabilities to Jiuzhitang, leveraging its extensive platform operation expertise, robust supply-chain capabilities, and industry-leading "Medicine + Pharmacy" ecosystem. Together with Jiuzhitang, JD Health will deliver more convenient, professional, and high-quality health products and services to the public, enabling Jiuzhitang’s premium, high-standard offerings to reach a wider audience. Meanwhile, Jiuzhitang will also fully capitalize on its strong expertise in pharmaceuticals and the broader healthcare sector, combining its product development and service capabilities with JD Health to co-create a new "Internet + Healthcare" service ecosystem. This collaboration not only supports Jiuzhitang’s own digital transformation but also helps elevate and modernize the nation’s healthcare service system.
In terms of products, Jiuzhitang boasts a comprehensive portfolio spanning OTC products, prescription drugs, and greater health-related offerings. Meanwhile, JD Health possesses robust online marketing resources for pharmaceuticals and health products, along with expert medical professionals, extensive distribution channels, and a vast customer base for its telehealth services. Together, the two companies will leverage their respective strengths to collaborate closely in areas such as pharmaceutical sales, academic marketing, and innovative health products, aiming to enhance brand visibility, drive C2M-based customized partnerships, continuously scale up sales, and ultimately create new market-leading products.
In terms of its "Yao Jing Cai" supply chain, as a pharmaceutical procurement and service platform under JD Health, "Yao Jing Cai" boasts partnerships with over 230,000 pharmacies, clinics, and other customers. Under this strategic collaboration, Jiuzhitang will join forces with "Yao Jing Cai" to deepen cooperation in areas such as product marketing and promotion, exclusive product specifications or differentiation, as well as hospital-based wholesale and centralized procurement initiatives. Together, they aim to expand distribution channels and enhance the efficiency of pharmaceutical logistics.
In addition, the two parties will also engage in comprehensive collaboration across various areas, including traditional Chinese medicine "Internet + Healthcare" services, joint development of specialized departments such as oncology, infertility, and sleep disorders, as well as the "Internet + Physician Education" project—aiming to seamlessly integrate resources throughout the entire pharmaceutical industry chain.
Xin Lijun, Senior Vice President of JD Group and CEO of JD Health, expressed his hope that the strategic partnership between Jiuzhitang and JD Health—leveraging their respective strengths and complementary advantages—will help seize the burgeoning opportunities in "Internet + Traditional Chinese Medicine," enabling them to pool top-tier resources and contribute significantly to the revitalization of TCM.
Li Zhenguo, President of Jiuzhitang Group and Chairman of Jiuzhitang Co., Ltd., expressed his hope that the collaboration between the two parties will help Jiuzhitang embrace the power of the internet, injecting strong momentum for growth. He also hopes this partnership will set a historic benchmark in the health industry sector.
Related News
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy